Jennifer Champoux, Chief Operating Officer at Monte Rosa Therapeutics, sold GLUE on Jun 17, 2026
Data as of Oct 16
▼ SELL$41.3K2,176 shares at $19.00Jennifer Champoux Chief Operating OfficerGLUE Monte Rosa Therapeutics, Inc.
- Traded
- Jun 17, 2026
- Disclosed
- Jun 18, 2026
- Filed
- 1 day after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
GLUE since disclosure
−46.8%
after the sale
Similar stocks (XLV) since disclosure
+18.3%
XLV — its sector index fund
Change in closing price from Jun 18, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.